Skip to main content
Exact Dx synthetic data · demonstration

Staff surface Definitions and reviews

Definition library

Every executable definition and catalogue entry, with the threshold quoted from its source. All are drafts pending clinical and coding review; a definition shows as reviewed only after an approval is recorded. Default set library_default_set@1.0.

Coder worklist

Cancer-treatment adverse-event grading scale (NCI CTCAE): off by default

CTCAE grades describe adverse events in people receiving cancer treatment, usually in trials; they are not diagnostic criteria, and several grades depend on the laboratory reference range or on clinical descriptors that are not encoded. Using them outside that setting is a local decision for the clinical reviewer.

Current: Off (default) When on, grading entries are shown only as "another published definition gives …" or as values needing clinical judgement; they never raise a "not stated" item.

CDI or coding staff can change this setting and record reviews: switch the demo user.

1 of 66 shown.

Severe hypercholesterolaemia, LDL-C ≥190 mg/dL (2018 AHA/ACC cholesterol guideline) aha2018_severe_hypercholesterolaemia@1.0 1 Draft · pending review draft — pending clinical and coding review
Status
draft — pending clinical and coding review (draft — requires clinical and coding review)
Condition
Severe hypercholesterolaemia
Tier
1
Use here
default set (ldl)
Edition
2018 (2018)
Second source
National Heart, Lung, and Blood Institute, National Cholesterol Education Program (NIH Publication No. 01-3670) 2001 · agrees: ATP III calls ≥190 mg/dL 'very high'.
Contested
no: Same 190 mg/dL boundary as ATP III 'very high'.

American Heart Association / American College of Cardiology and partner societies, 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

aha2018_severe_hypercholesterolaemia@1.0
Severe Hypercholesterolemia (LDL-C ≥190 mg/dL [≥4.9 mmol/L])

2018 (2018) · Section 4.2 heading; Top 10 Take-Home Message 4 · source

Review

No review recorded yet.